SCHEMBL6833176

SCHEMBL6833176

CC(C)Sc1ccncc1C(N)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT3 Q9NTG7 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
ALDH1A1 P00352 3/20 0.40
KMT2A Q03164 2/20 0.40
SLC22A12 Q96S37 4/20 0.40
CDC7 O00311 2/20 0.39
KDM4E B2RXH2 3/20 0.39
HTT P42858 1/20 0.39
MKNK1 Q9BUB5 2/20 0.38
MKNK2 Q9HBH9 2/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
CA14 Q9ULX7 2/20 0.37
F7 P08709 1/20 0.37
F3 P13726 1/20 0.37
SARM1 Q6SZW1 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.37
SIRT6 Q8N6T7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1327240 0.81 SIRT3 (0.59) SIRT3TDP1ALDH1A1KMT2ASLC22A12
SCHEMBL1328542 0.77 SIRT3 (0.54) SIRT3TDP1ALDH1A1KMT2ASLC22A12
SCHEMBL6781811 0.75 SIRT1 (0.55) ALDH1A1KMT2AKDM4EHTTCA12
SCHEMBL740928 0.74 TDP1 (0.51) SIRT3TDP1ALDH1A1SLC22A12CDC7
SCHEMBL6215853 0.74 SIRT3 (0.59) SIRT3TDP1ALDH1A1KMT2ACDC7
SCHEMBL16703743 0.73 HASPIN (0.40) TDP1ALDH1A1KMT2ASLC22A12KDM4E
SCHEMBL5087701 0.72 SIRT1 (0.65) SIRT3TDP1SLC22A12CDC7KDM4E
SCHEMBL1687197 0.72 TDP1 (0.67) SIRT3TDP1ALDH1A1KMT2ACDC7
SCHEMBL1330970 0.72 TDP1 (0.67) SIRT3TDP1ALDH1A1KMT2ACDC7
SCHEMBL20196932 0.71 KMT2A (0.41) TDP1ALDH1A1KMT2AKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004087669-A1 NOVEL QUINOLINE, TETRAHYDROQUINAZOLINE, AND PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO. LTD. (JP) 2004-10-14 WO disclosed